Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002681846 | SCV002992361 | likely benign | RASopathy | 2023-03-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004066916 | SCV003626374 | uncertain significance | Cardiovascular phenotype | 2022-07-27 | criteria provided, single submitter | clinical testing | The c.321-4C>G intronic alteration consists of a C to G substitution 4 nucleotides before coding exon 3 in the RAF1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |